Sonic Healthcare Limited
(ASX:SHL) has announced its signed a binding agreement to acquire Germany’s Medical Laboratory Breman (MLB).
The Laboratory runs two practices in North-West Germany with revenues of about 30 million Euros per annum.
Sonic will use its existing cash and debt facilities to fund the 63 million Euro purchase.
The transaction will also be accretive to Sonic’s EPS by approximately 2% in the first year.
Subject to approval and other usual closing conditions, the sale is expected to be completed in July 2017.
Sonic Healthcare Limited
(ASX:SHL) posted a net profit of $466.0 million at 30 June 2016.
